Precision Biosciences Inc (DTIL) SEC Filings — 2024
27 SEC filings for Precision Biosciences Inc (DTIL) in 2024.
Filings
- Precision Biosciences Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Precision Biosciences Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Precision Biosciences Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Precision Biosciences Inc SC 13G Filing — SC 13G · Nov 14, 2024
- Precision BioSciences Q3 2024 Update — 10-Q · Nov 4, 2024
- Precision BioSciences Sells Gene Editing Business — 8-K · Oct 24, 2024
- Precision BioSciences Appoints New CMO, Director — 8-K · Sep 12, 2024
- Precision BioSciences Sells Gene Editing Business — 8-K · Sep 3, 2024
- Precision BioSciences Q2 2024 Update — 10-Q · Aug 1, 2024
- Precision BioSciences Reports Board & Executive Changes — 8-K · Jun 10, 2024
- Precision BioSciences Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Precision BioSciences Sells Gene Editing Unit to Syngenta for $100M — 8-K · May 8, 2024
- Precision BioSciences Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 25, 2024
- Precision BioSciences Terminates Novartis Gene Therapy Deal — 8-K · Apr 16, 2024
- Precision BioSciences Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 27, 2024
- Precision Biosciences Inc SC 13G Filing — SC 13G · Mar 18, 2024
- Precision Biosciences Inc SC 13G Filing — SC 13G · Mar 14, 2024
- Precision Biosciences Inc SC 13G Filing — SC 13G · Mar 11, 2024
- Precision BioSciences Sells Gene Editing Unit to Syngenta for $100M — 8-K · Mar 1, 2024
- Precision Biosciences Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Precision BioSciences Files Bylaw Amendments — 8-K · Feb 13, 2024
- Capital World Investors Amends 9.9% Stake in Precision BioSciences — SC 13G/A · Feb 9, 2024
- Tang Capital Partners Discloses Stake in Precision BioSciences — SC 13G · Feb 5, 2024
- DTIL Files 8-K on Officer/Director Changes & Compensation — 8-K · Jan 23, 2024
- Precision BioSciences Confirms Nasdaq Listing & Common Stock Details — 8-K · Jan 19, 2024
- Precision BioSciences to Vote on Reverse Stock Split Jan 18 — DEFA14A · Jan 12, 2024
- Precision BioSciences Reports Material Agreement, Equity Sales — 8-K · Jan 11, 2024